Rhabdomyolysis and statins
The Mayo Clinic reassures that “the risk of very serious side effects is extremely low, and calculated in a few cases per million people taking statins”.
In a report on statin-induced rhabdomyolysis published in the journal Physiotherapy Canada, researchers sought to identify which statins may carry a higher risk of rhabdomyolysis.
They found that Simvastatin was the most common medication reported in association with rhabdomyolysis, most commonly taken at a dose of 40 mg/day.
The report continued: “Fewer cases reported the use of cerivastatin, lovastatin, rosuvastatin, pravastatin and fluvastatin.”